ASP Isotopes says ENDRA files S-4 for planned Noble Africa merger

• Merger Sub, a unit of ENDRA Life Sciences, is set to merge into Noble Africa, a unit of ASP Isotopes.
• Noble Africa will survive the merger as a direct wholly owned subsidiary of ENDRA.
• The deal was agreed on June 25, 2026, subject to customary closing conditions.
• ENDRA filed an S-4 registration statement on Oct. 2, 2026, including information on ASP subsidiary Renergen.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ASP Isotopes Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001477932-26-005971), on October 02, 2026, and is solely responsible for the information contained therein.